Found: 40
Select item for more details and to access through your institution.
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 784, doi. 10.1016/j.clbc.2023.05.012
- By:
- Publication type:
- Article
SUMMIT Reveals Promise of Neratinib in HE2 Mutant Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2022, p. 8
- By:
- Publication type:
- Article
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2014, v. 14, n. 3, p. 154, doi. 10.1016/j.clbc.2013.12.012
- By:
- Publication type:
- Article
Targeting Tumor Angiogenesis in Combination with Endocrine Therapy in Patients with Hormone-Receptor Positive Metastatic Breast Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2011, v. 3, n. 4, p. 24
- By:
- Publication type:
- Article
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 319, doi. 10.1007/s10549-022-06797-9
- By:
- Publication type:
- Article
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 415, doi. 10.1007/s10549-021-06209-4
- By:
- Publication type:
- Article
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 227, doi. 10.1007/s10549-020-05726-y
- By:
- Publication type:
- Article
Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231216095
- By:
- Publication type:
- Article
Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231152843
- By:
- Publication type:
- Article
How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 12, p. 4702, doi. 10.1245/s10434-020-08888-7
- By:
- Publication type:
- Article
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 742, doi. 10.1007/s10637-017-0445-0
- By:
- Publication type:
- Article
Voxelwise analysis of simultaneously acquired and spatially correlated <sup>18</sup>F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer.
- Published in:
- Magnetic Resonance in Medicine, 2017, v. 78, n. 3, p. 1147, doi. 10.1002/mrm.26505
- By:
- Publication type:
- Article
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00251-7
- By:
- Publication type:
- Article
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Balancing the Risks and Benefits of Extended Adjuvant Endocrine Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 2, p. 105
- By:
- Publication type:
- Article
Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 141, n. 2, p. 167, doi. 10.1007/s10549-013-2681-0
- By:
- Publication type:
- Article
Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 106, n. 3, p. 315, doi. 10.1007/s10549-007-9518-7
- By:
- Publication type:
- Article
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 8, p. 1796, doi. 10.1002/cam4.4579
- By:
- Publication type:
- Article
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.810023
- By:
- Publication type:
- Article
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 11, p. e1916211, doi. 10.1001/jamanetworkopen.2019.16211
- By:
- Publication type:
- Article
F-FDG PET/CT in metastatic invasive lobular breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.247882
- By:
- Publication type:
- Article
Head-to-head evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in metastatic invasive lobular breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.247882
- By:
- Publication type:
- Article
Head-to-head evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in metastatic invasive lobular breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.247882
- By:
- Publication type:
- Article
Head-to-head evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in metastatic invasive lobular breast cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.247882
- By:
- Publication type:
- Article
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 900, doi. 10.2967/jnumed.117.202010
- By:
- Publication type:
- Article
Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, p. 81S, doi. 10.2967/jnumed.115.157941
- By:
- Publication type:
- Article
Molecular Imaging of Biomarkers in Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, p. 53S, doi. 10.2967/jnumed.115.157909
- By:
- Publication type:
- Article
Measuring Tumor Metabolism by <sup>18</sup>F-FDG PET Predicts Outcome in a Multicenter Study: A Step Off in the Right Direction.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 1, doi. 10.2967/jnumed.114.151175
- By:
- Publication type:
- Article
Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 430, doi. 10.1159/000514345
- By:
- Publication type:
- Article
Hepatic Arterial Infusion and Systemic Chemotherapy for Breast Cancer Liver Metastases.
- Published in:
- Breast Journal, 2013, v. 19, n. 1, p. 96, doi. 10.1111/tbj.12050
- By:
- Publication type:
- Article
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 7, p. 1344, doi. 10.1002/cncr.27842
- By:
- Publication type:
- Article
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5454, doi. 10.1002/cncr.27579
- By:
- Publication type:
- Article
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00699-3
- By:
- Publication type:
- Article
Genome-Based Risk Prediction for Early Stage Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 10, p. 1019, doi. 10.1634/theoncologist.2014-0124
- By:
- Publication type:
- Article
Ganetespib: research and clinical development.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1849, doi. 10.2147/OTT.S65804
- By:
- Publication type:
- Article
Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4967, doi. 10.1002/cncr.33153
- By:
- Publication type:
- Article